HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
Basilea Pharmaceutica AG - Therapeutic Competitors.
-
M2 Presswire; Jun 22, 2009; 700+ Words
...Companies and Markets: Basilea Pharmaceutica AG - Therapeutic Competitors...COMMUNICATIONS RDATE:22062009 Basilea Pharmaceutica AG - Therapeutic Competitors...Company and Market Analysis 'Basilea Pharmaceutica AG - Therapeutic Competitors...
-
-
Basilea Pharmaceutica AG-Detailed Product Pipeline.
-
M2 Presswire; Mar 11, 2009; 572 Words
...March 2009-www.companiesandmarkets.com: Basilea Pharmaceutica AG-Detailed Product Pipeline(C)1994-2009...companiesandmarkets.com adds new report: Basilea Pharmaceutica AG-Detailed Product Pipeline Pipeline Reports contain...
-
-
Basilea Pharmaceutica AG-Financial Company Report.
-
M2 Presswire; Feb 12, 2009; 700+ Words
...February 2009-www.companiesandmarkets.com: Basilea Pharmaceutica AG-Financial Company Report(C)1994-2009 M2...companiesandmarkets.com adds new report: Basilea Pharmaceutica AG-Financial Company Report Financial Company Reports...
-
-
Basilea Pharmaceutica AG-Therapeutic Competitors.
-
M2 Presswire; Jan 29, 2009; 700+ Words
...January 2009-www.companiesandmarkets.com: Basilea Pharmaceutica AG-Therapeutic Competitors(C)1994-2009 M2...companiesandmarkets.com adds new report: Basilea Pharmaceutica AG-Therapeutic Competitors Therapeutic Competitors...
-
-
Basilea Pharmaceutica AG, a Swiss biotechnology company, said an experimental drug helped relieve patients with a chronic skin disease and will be submitted to regulators this year.(RESEARCH & TECHNOLOGY)(Brief article)
-
MondayMorning; Feb 26, 2007; 700+ Words
Basilea Pharmaceutica AG, a Swiss biotechnology company, said an experimental drug helped...second to show results in the final stage of tests this year after Basilea's antibiotic ceftobiprole helped fight skin infections. In the study...
-
-
USPTO Issues Trademark BASILEA to Basilea Pharmaceutica for Chemical Substances for Use in Manufacture of Pharmaceutical Preparations, Pharmaceutical Preparations
-
US Fed News Service, Including US State News; Oct 6, 2009; 700+ Words
...ALEXANDRIA, Va., Oct. 6 -- Basilea Pharmaceutica AG, Basel, Switzerland, has been issued the trademark BASILEA (Reg. No 3689485; International...blue appears in the wording "BASILEA" and in the design of the oval...
-
-
Publication No. WO/2009/098320 Published on Aug. 13, Assigned to Basilea Pharmaceutica for Macrolide, Usage (Swiss, German Inventors)
-
US Fed News Service, Including US State News; Aug 18, 2009; 386 Words
...Bernhard Reinelt, Germany, have developed macrolides and uses of macrolides. The patent has been assigned to Basilea Pharmaceutica AG, Basel, Switzerland. According to an abstract posted by the World Intellectual Property Organization, the...
-
-
Publication No. WO/2009/106419 Published on Sept. 3, Assigned to BASILEA PHARMACEUTICA for Macrolide, Usage (Swiss, German Inventors)
-
US Fed News Service, Including US State News; Sep 8, 2009; 454 Words
...Bernhard Reinelt, Germany, have developed a new macrolides and their use. The patent has been assigned to BASILEA PHARMACEUTICA AG, Basel, Switzerland. According to an abstract posted by the World Intellectual Property Organization, the...
-
-
Publication No. WO/2009/127623 Published on Oct. 22, Assigned to Basilea Pharmaceutica for Crystalline (Italian, German Inventors)
-
US Fed News Service, Including US State News; Oct 29, 2009; 372 Words
...Heubes and Michael Schleimer, both of Germany, have developed a Crystalline. The patent has been assigned to Basilea Pharmaceutica AG, Basel, Switzerland. According to an abstract posted by the World Intellectual Property Organization: "A...
-
-
Basilea Shares Sink on Delay in EU Approval of Zevtera.
-
BioWorld International; Feb 25, 2009; 700+ Words
...International Correspondent Shares in Basilea Pharmaceutica AG dropped by more than 36 percent...III trials. The delay prompted Basilea to launch a claim for damages...Basel, Switzerland-based Basilea and Johnson & Johnson, of New...
-
-
Basilea Becomes Sole Owner Of BAL5788; Roche Opts Out.
-
BIOWORLD Today; Nov 3, 2009; 700+ Words
...BioWorld International Correspondent Basilea Pharmaceutica AG gained outright ownership of its...dropped Basel, Switzerland-based Basilea's shares, which trade on the...the company CHF205.8 million. Basilea, which was formed in 2000 as...
-
-
BASILEA BECOMES SOLE OWNER OF BAL5788; ROCHE OPTS OUT.
-
BIOWORLD Today; May 26, 2004; ; 700+ Words
...BioWorld International Correspondent Basilea Pharmaceutica AG gained outright ownership of its...dropped Basel, Switzerland-based Basilea's shares, which trade on the...the company CHF205.8 million. Basilea, which was formed in 2000 as...
-
-
Launches Arbitration Claim Against J&J Basilea Shares Sink on Delay in EU Approval of Zevtera.
-
BIOWORLD Today; Feb 25, 2009; ; 700+ Words
...Today Correspondent Shares in Basilea Pharmaceutica AG dropped by more than 36 percent...III trials. The delay prompted Basilea to launch a claim for damages...Basel, Switzerland-based Basilea and Johnson & Johnson...
-
-
Basilea files claim against J&J over drug.
-
Pharma Marketletter; Mar 2, 2009; 585 Words
Swiss firm Basilea Pharmaceutica AG has filed a claim against Johnson...licensed the potential blockbuster from Basilea and is responsible for conducting...inspections had been done, shares in Basilea plummetted 36.8% to 70 Swiss francs...
-
-
Basilea Racks Up European Approvals for Alitretinoin.
-
BioWorld International; Oct 22, 2008; 700+ Words
...BioWorld International Correspondent Basilea Pharmaceutica AG continued to collect European...Toctino is the second product from Basilea's pipeline to gain regulatory...Switzerland. In other news, Basilea said it would present new data...
-
-
Approval Letter on Ceftobiprole Sends Basilea Shares Plunging.
-
BioWorld International; Mar 19, 2008; 700+ Words
...BioWorld International Correspondent Basilea Pharmaceutica AG took a heavy pounding on the Swiss...foot infections, submitted by Basilea's partner, Johnson & Johnson...Basel, Switzerland-based Basilea said the FDA now has communicated...
-
-
Basilea's Toctino medicine approved for sale in Switzerland.
-
ADP News Switzerland; Oct 14, 2009; 425 Words
(ADPnews) - Oct 14, 2009 - Swiss Basilea Pharmaceutica AG (SWF:BSLN) said today regulatory authority Swissmedic...countries and Canada. For the current fiscal year Basilea expects the medicine to bring revenue ranging from...
-
-
Canada approves sale of Swiss Basilea's Toctino drug.
-
ADP News Switzerland; Nov 18, 2009; 435 Words
...ADPnews) - Nov 18, 2009 - Swiss biopharmaceutical firm Basilea Pharmaceutica AG (SWF:BSLN) announced today its chronic hand eczema...already marketed in Denmark, Germany and the UK, Basilea said. The medication has also received marketing...
-
-
Basilea Falls as FDA Delays Ceftobiprole Decision Again.
-
BioWorld International; Dec 3, 2008; 700+ Words
...for Swiss biotech Basilea Pharmaceutica Ltd. and co-development...J subsidiary and Basilea have 12 months to...at Bank Vontobel AG in Zurich. "It...Switzerland-based Arpida AG failed to show in...agency's response to Basilea came as "a big surprise...
-
-
CHMP Votes Unanimously in Favor of Ceftobiprole.
-
BioWorld International; Nov 26, 2008; 700+ Words
...BioWorld International Correspondent Basilea Pharmaceutica AG and its partner Johnson & Johnson...at Basel, Switzerland-based Basilea, provided few details on the...accepted onto hospital formularies. Basilea is entitled to co-promote the...
|
|